Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Wybe Martin Kast"'
Autor:
Jacques Neefjes, Wybe Martin Kast, Anne Neisig, C. J. M. Melief, Michel P. M. Vierboom, J. W. Drijfhout, ter Schegget J, Mariet C.W. Feltkamp
Publikováno v:
Scopus-Elsevier
Anchor residues in cytotoxic T-lymphocyte (CTL) epitope-bearing peptides are buried deep in the major histocompatibility complex (MHC) class I antigen-presenting groove and are essential for binding to MHC class I molecules. We investigated whether a
Publikováno v:
Transplantation. 62:1485-1491
The mouse strains C57BL/6 (B6, H2 b ) and K bm1 mutant bm1 have a defined difference of three amino acids at position 152, 155, and 156 in the MHC class I K molecule. This causes a change in the side and the bottom of the antigen presenting groove of
Autor:
S.H. van der Burg, Andreas J.A. Bremers, Wybe Martin Kast, Elisabeth Ras, Jan W. Drijfhout, Willemien E. Benckhuijsen, C. J. M. Melief
Publikováno v:
Human Immunology
A peptide-binding assay employing the HLA class I molecules on intact human B cells is described. The peptide antigens are stripped from the HLA class I molecules by mild acid treatment, after which the cells are incubated with a FL-labeled reference
Autor:
Miriam Ossevoort, Wybe Martin Kast, Mariet C.W. Feltkamp, Cornelis J. M. Melief, K. J. H. Van Veen
Publikováno v:
Journal of Immunotherapy. 18:86-94
Previously we have demonstrated that two doses of a cytotoxic T lymphocyte (CTL) epitope-based peptide vaccine of human papillomavirus type 16 (HPV 16) E7 aa 49-57 elicit protection against outgrowth of HPV 16-transformed tumor cells (C3 cells) in B6
Autor:
C.J.H. van de Velde, Peter J. K. Kuppen, S.H. van der Burg, C. J. M. Melief, Andreas J.A. Bremers, Wybe Martin Kast
Publikováno v:
Journal of Immunotherapy
In the development of cytotoxic T lymphocyte (CTL)-mediated immunotherapy, the identification of CTL epitopes is of crucial importance. Binding of a peptide to major histocompatibility complex (MHC) class I molecules is one of the prerequisites for i
Autor:
Monique J. Kleijmeer, Miriam Ossevoort, M. Van De Keur, Peter Kenemans, C. J. M. Melief, M. P. M. Vierboom, Wybe Martin Kast, Hans W. Nijman, Hans J. Geuze, Viola Oorschot
Publikováno v:
The Journal of Experimental Medicine
Dendritic cells (DC) represent potent antigen-presenting cells for the induction of T cell-dependent immune responses. Previous work on antigen uptake and presentation by human DC is based largely on studies of blood DC that have been cultured for va
Autor:
E. I. H. van der Voort, L. A. Gravestein, Maarten Zijlstra, C. J. M. Melief, M. J. W. Visseren, M. Koot, Wybe Martin Kast, H. J. Schoenmakers
Publikováno v:
Journal of Immunotherapy. 15:119-128
Systemic administration of recombinant interleukin (rIL)-2 to cancer patients has met with limited clinical success since, despite significant antitumor effects, its use is associated with severe toxicity. Local production of IL-2 by IL-2 gene transf
Autor:
Frank Momburg, Wybe Martin Kast, J. W. Drijfhout, C.J.H. van de Velde, S.H. van der Burg, Anneke Brand, Peter Kenemans, Hans W. Nijman, J. G. A. Houbiers, Cornelis J. M. Melief
Publikováno v:
European Journal of Immunology
The central role of the p53 tumor suppressor gene product in oncogenesis is gradually being clarified. Point mutations in the p53 tumor suppressor gene are common in most human cancers and are often associated with p53 protein overexpression. Overexp
Autor:
C. J. M. Melief, M. P. M. Vierboom, S.H. van der Burg, Peter Kenemans, J. G. A. Houbiers, Wybe Martin Kast, Hans W. Nijman
Publikováno v:
Journal of Immunotherapy
We previously described a motif prediction of major histocompatibility complex allele-specific peptides and an in vitro assay for actual measurement of peptide binding to human leukocyte antigen HLA-A2.1 molecules. Using this method we have identifie
Autor:
C. J. M. Melief, E. van Twuyver, J. M. Wilmink, I. J. M. ten Berge, R. J. D. Mooijaart, L. P. de Waal, A. R. van der Horst, Wybe Martin Kast
Publikováno v:
New England journal of medicine, 325(17), 1210-1213. Massachussetts Medical Society
BACKGROUND: Blood transfusion before organ transplantation has a beneficial effect on allograft survival; the mechanism of this effect has remained a mystery. In murine models, the presence of common histocompatibility antigens in the blood donor and